Back

Biogen
BIIB
$248.71
-1.94%
Overview
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune...
Open
$254.00
Prior close
$253.62
Today's high
$255.00
Today's low
$247.99
52 Week high
$258.78
52 Week low
$148.51
News
GlobeNewsWire • 5 days ago • BIIB
Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026

MarketBeat • 5 days ago • BIIB
Biogen Q3 Earnings Call Highlights

Zacks Investment Research • 5 days ago • BIIB
BIIB's Q3 Earnings Beat, New Drugs Aid Sales, '26 EPS View Tightened

Zacks Investment Research • 5 days ago • BIIB
Big Day for Econ Data, Hyperscaler Earnings

Zacks Investment Research • 5 days ago • BIIB
Biogen (BIIB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
